A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis
Background and purpose: Recently, the use of immunotoxins for targeted cancer therapy has been proposed, to find new anticancer drugs with high efficacy on tumor cells with minimal side effects on normal cells. we designed and compared several arazyme (AraA)-based fusion proteins with different liga...
Saved in:
Main Authors: | Rezvan Mehrab (Author), Hamid Sedighian (Author), Fattah Sotoodehnejadnematalahi (Author), Raheleh Halabian (Author), Abbas Ali Imani Fooladi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line
by: Rezvan Mehrab, et al.
Published: (2024) -
Designing and Analyzing the Structure of DT-STXB Fusion Protein as an Anti-tumor Agent: An in Silico Approach
by: Zeynab Mohseni Moghadam, et al.
Published: (2019) -
Development of a novel denture care agent with highly active enzyme, arazyme
by: Jong-Hoon Kim, et al.
Published: (2021) -
Genetic Diversity of ctxB Gene Among Classical O1 and El Tor Strains of Vibrio cholerae using High-Resolution Melting Curve Analysis
by: Mahdieh Mahboobi, et al.
Published: (2020) -
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020)